Sugi Predict

Sugi Predict / Compounds / SCHEMBL20139723

SCHEMBL20139723

SCHEMBL20139723

C=CCO[C@H]1O[C@H](COCc2ccccc2)[C@H](O)[C@H](OCc2ccccc2)[C@H]1OCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 2/20 0.47
▸ NT5E P21589 1/20 0.45
▸ GJB2 P29033 1/20 0.45
▸ PTPN1 P18031 6/20 0.43
▸ CDC25B P30305 6/20 0.43
▸ PTPN2 P17706 2/20 0.43
▸ PTPN6 P29350 2/20 0.43
▸ PTPN11 Q06124 2/20 0.43
▸ TACR1 P25103 1/20 0.42
▸ SSTR1 P30872 1/20 0.42
▸ SSTR2 P30874 1/20 0.42
▸ SSTR4 P31391 1/20 0.42
▸ SSTR3 P32745 1/20 0.42
▸ SSTR5 P35346 1/20 0.42
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ BCHE P06276 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7567425 1.00 SLC6A2 (0.47) SLC6A2NT5EGJB2PTPN1CDC25B
SCHEMBL22683015 1.00 SLC6A2 (0.47) SLC6A2NT5EGJB2PTPN1CDC25B
SCHEMBL7567428 1.00 SLC6A2 (0.47) SLC6A2NT5EGJB2PTPN1CDC25B
SCHEMBL4421768 0.91 NT5E (0.48) SLC6A2NT5EGJB2PTPN1CDC25B
SCHEMBL2589252 0.91 NT5E (0.48) SLC6A2NT5EGJB2PTPN1CDC25B
SCHEMBL27828449 0.91 NT5E (0.48) SLC6A2NT5EGJB2PTPN1CDC25B
SCHEMBL8708672 0.91 GJB2 (0.52) SLC6A2NT5EGJB2PTPN1CDC25B
SCHEMBL19731779 0.91 NT5E (0.48) SLC6A2NT5EGJB2PTPN1CDC25B
SCHEMBL13646610 0.90 SLC6A2 (0.44) SLC6A2NT5EGJB2PTPN1CDC25B
SCHEMBL8721436 0.89 SSTR1 (0.52) NT5EPTPN1CDC25BPTPN2PTPN6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210238170-A1 5,5-Difluoro- and 5-Fluoro-5-Methyl-C-Glycoside Derivatives Useful As Dual SGLT1 / SGLT2 Modulators JANSSEN PHARMACEUTICA NV (BE) 2021-08-05 — — US disclosed
US-10815210-B2 Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators JANSSEN PHARMACEUTICA NV (BE) 2020-10-27 — — US disclosed
WO-2019215633-A1 5,5-DIFLUORO- AND 5-FLUORO-5-METHYL-C-GLYCOSIDE DERIVATIVES USEFUL AS DUAL SGLT1 / SGLT2 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-11-14 — — WO disclosed
WO-2018089449-A1 BENZOCYCLOBUTANE DERIVATIVES USEFUL AS DUAL SGLT1/SGLT2 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-05-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10815210-B2 Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators SLC5A2, SLC5A1, SLC2A2 SLC6A2 196/4885NT5E 3828/4885GJB2 375/4885
US-20210238170-A1 5,5-Difluoro- and 5-Fluoro-5-Methyl-C-Glycoside Derivatives Useful As Dual SGLT1 / SGLT2 Modulators SLC5A2, SLC5A1, SLC2A4 SLC6A2 93/4885NT5E 966/4885GJB2 3282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.